Summary of 2011/12 QOF indicator changes, points and thresholds

Similar documents
Summary of 2012/13 QOF Changes

SUMMARY OF CHANGES TO QOF 2014/15 - ENGLAND CLINICAL

14/15 Threshold 15/16 Points 15/16. Points. Retired Replaced by NM82/AF007. Replacement NO CHANGE

17/18 Threshold 18/19 Points 18/19. Points NO CHANGE NO CHANGE NO CHANGE

New indicators to be added to the NICE menu for the QOF and amendments to existing indicators

SUMMARY OF CHANGES TO QOF 2017/18 - ENGLAND CLINICAL

The contractor establishes and maintains a register of patients with AF

POTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME. Indicator Assessment Report

12/13 Threshold. 13/14 Points. 12/13 Points. Minor wording change (noted in bold) mnth change

Quality And Outcomes Framework Guidance for the GMS Contract Wales 2018/19. June 2018

2. Quality and Outcomes Framework: new NICE recommendations

Quality and Outcomes Framework guidance for GMS contract 2009/10. Delivering investment in general practice

Scottish Quality and Outcomes Framework 2013/2014. Guidance for NHS Boards and GP practices

The following principles relating to the Quality and Outcomes Framework (QOF) were agreed by the negotiators.

Scottish Quality and Outcomes Framework guidance for GMS contract 2015/16

QOF (England): clinical indicators

National Primary Care Research and Development Centre and University of York Health Economics Consortium (NICE External Contractor)

Ref. No. Title Quality Dimension

Quality And Outcomes Framework Guidance for the GMS Contract Wales 2013/14. May 2013

2015/16 General Medical Services (GMS) contract Quality and Outcomes Framework (QOF)

Quality And Outcomes Framework Guidance for the GMS Contract Wales 2014/15. June 2014

Royal Crescent Surgery

GUIDE TO CODING AND DISEASE REGISTERS FOR THE CONTRACT (Scottish) Version 1.0. January 2014

NICE Indicator Programme. Consultation on proposed amendments to current QOF indicators

Indicator Points Payment stages. HF 1: The practice can produce a register of patients with 4 heart failure

Cardiology The interface between Primary and Secondary Care

Changes to QoF 2011/12

Improving physical health for people with mental health conditions in primary care

GUIDE TO CODING AND DISEASE REGISTERS FOR THE CONTRACT (Scottish) Version 1.0

Working with the changes to QoF 08/09

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

CQC Insight. NHS GP practices Indicators and methodology

Physical Health Checks

GP Insight Report. The Family Practice CQC ID:

Delivering effective physical health checks in practice. Dr Sheila Hardy, Education Fellow, UCLPartners and Honorary Senior Lecturer, UCL 9.12.

Optimising Hypertension Management Clair Huckerby Pharmaceutical Adviser- Medicines Optimisation Lead

Coronary Heart Disease

Time Series Analysis for selected clinical indicators from the Quality and Outcomes Framework

OCCG SERVICE SPECIFICATION (2018/19) Improving Physical Health in Patients with a Severe Mental Illness

Community network profile Herne Bay

GP Insight Report. Oaklands CQC ID:

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Guideline scope Hypertension in adults (update)

Prescribed Minimum Benefits treatment guidelines 2013

Trends and Variations in General Medical Services Indicators for Coronary Heart Disease: Analysis of QRESEARCH Data

Four Years of NHS Health Checks in Barnsley - Outcomes and Inequalities

Diabetes. Ref HSCW 024

2018 MIPS Reporting Family Medicine

National Diabetes Audit

National Diabetes Audit

HERTFORDSHIRE MEDICINES MANAGEMENT COMMITTEE (HMMC) DABIGATRAN RECOMMENDED What it is Indications Date decision last revised

National Diabetes Audit

UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator

Practice-Level Executive Summary Report

Volume 2; Number 11 July 2008

QOF indicator area: Chronic Obstructive Pulmonary disease (COPD)

Primary Care Commission Study Visit. 26 March 2015

National Diabetes Audit, Report 1: Care Processes and Treatment Targets

Vascular checks a vascular risk assessment and management. Heather White Deputy Branch Head Vascular Programme

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE General practice Indicators for the NICE menu

UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator

Cardiovascular disease profile

DIABETES MEASURES GROUP OVERVIEW

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Chronic Benefit Application Form Cardiovascular Disease and Diabetes

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal

proposed set to a required subset of 3 to 5 measures based on the availability of electronic

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults

What s new in cardiovascular disease risk assessment and management for primary care clinicians

National Diabetes Audit

Choosing Wisely Long Term Care Uniquely Canadian

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes

Survey Scottish Diabetes. Survey Monitoring Group

How a universal health system reduces inequalities: lessons from England

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Outcomes of diabetes care in England and Wales. A summary of findings from the National Diabetes Audit : Complications and Mortality reports

ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study

2017 MSSP Clinical Quality Measures

Shaping Diabetes Services in Southern Derbyshire. A vision for Diabetes Services For Southern Derbyshire CCG

Dementia Care Pathway

requesting information regarding prescribing incentive schemes in Canterbury and Coastal Clinical Commissioning Group

Guideline scope Persistent pain: assessment and management

NPSA SAFER LITHIUM THERAPY GUIDELINES FOR NHS LANARKSHIRE

GOVERNING BODY REPORT

Enhanced Service for people with dementia in Primary Care

Stroke secondary prevention. Gill Cluckie Stroke Nurse Consultant St. George s Hospital

2017 HEDIS Measures. PREVENTIVE SCREENING 2017 Measure Quality Indicator

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Integrated Community Diabetes Services (ICDS) GP Referral Guide Version 3 - October 2014

National Diabetes Insulin Pump Audit, England and Wales

2018 Commercial HMO/POS HEDIS 1 Results

Primary Care Benchmarking Project. David Holland, Keele University

Guidelines to assist General Practitioners in the Management of Type 2 Diabetes. April 2010

Complications of Diabetes: Screening and Prevention

New GMS Contract QOF Implementation. Dataset and Business Rules - Mental Health Indicator Set (MH) Wales

Transcription:

Summary of 2011/12 QOF indicator changes, points and thresholds Retirements 2010/11 QOF ID 2010/11 Indicator Wording Points Threshold CHD5 The percentage of patients with coronary heart disease whose notes have a record of blood 7 40-90% pressure in the previous 15 months CHD7 The percentage of patients with coronary heart disease whose notes have a record of total 7 40-90% cholesterol in the previous 15 months DM5 The percentage of patients with diabetes who have a record of HbA1c or equivalent in the 3 40-90% previous 15 months DM11 The percentage of patients with diabetes who have a record of the blood pressure in the 3 40-90% previous 15 months DM16 The percentage of patients with diabetes who have a record of total cholesterol in the previous 3 40-90% 15 months STR5 The percentage of patients with TIA or stroke who have a record of blood pressure in the notes 2 40-90% in the preceding 15 months MH7 The percentage of patients with schizophrenia, bipolar affective disorder and other psychoses 3 40-90% who do not attend the practice for their annual review who are identified and followed up by the practice team within 14 days of non attendance EP7 The percentage of patients age 18 and over on drug treatment for epilepsy who have a record of medication review involving the patient and/or carer in the previous 15 months Information4 If a patient is removed from a practice s list, the practice provides an explanation of the reasons in writing to the patient and information on how to find a new practice, unless it is perceived that such an action would result in a violent response by the patient 1 - Records21 Ethic origin is recorded for 100% of new registrations 1 - PE7 The percentage of patients who, in the appropriate national survey, indicated that they were able 23.5 70-90% to obtain a consultation with a GP (in England) or appropriate professional (in Scotland, Wales and NI) within 2 working days (in Wales this will be within 24 hours) PE8 The percentage of patients who, in the appropriate national survey, indicate that they are able to book an appointment with a GP more than 2 days ahead 35 60-90% Page 1 of 6

Replacement Indicators indicator wording amendments 2009/11 NICE 2011/12 QOF ID ID QOF ID 2011/12 Indicator Wording Points Threshold CHD11 NM07 CHD14 The percentage of patients with a history of myocardial infarction (from 1 April 10 40-80% 2011) currently treated with an ACE inhibitor (or ARB if ACE intolerant), aspirin or an alternative anti-platelet therapy, beta blocker and statin (unless a contraindication or side effects are recorded) CHD2 NM08 CHD13 For patients with newly diagnosed angina (diagnosed after 1 April 2011), the 7 40-90% percentage who are referred for specialist assessment PP1 NM06 PP1 In those patients with a new diagnosis of hypertension (excluding those with preexisting 8 40-70% CHD, diabetes, stroke and/or TIA) recorded between the preceding 1 April to 31 March: the percentage of patients aged 30 to 74 years who have had a face to face cardiovascular risk assessment at the outset of diagnosis (within 3 months of the initial diagnosis) using an agreed risk assessment tool DM23 NM14 DM26 The percentage of patients with diabetes in whom the last IFCC-HbA1c is 59 17 40-50% mmol/mol (equivalent to HbA1c of 7.5% in DCCT values) or less (or equivalent test/reference range depending on local laboratory) in the preceding 15 months DM24 - DM27 The percentage of patients with diabetes in whom the last IFCC-HbA1c is 64 8 40-70% mmol/mol (equivalent to HbA1c of 8% in DCCT values) or less (or equivalent test/reference range depending on local laboratory) in the preceding 15 months DM25 - DM28 The percentage of patients with diabetes in whom the last IFCC-HbA1c is 75 10 40-90% mmol/mol (equivalent to HbA1c of 9% in DCCT values) or less (or equivalent test/reference range depending on local laboratory) in the preceding 15 months DM9 NM13 DM29 The percentage of patients with diabetes with a record of a foot examination and risk classification: 1) low risk (normal sensation, palpable pulses), 2) increased risk (neuropathy or absent pulses), 3) high risk (neuropathy or absent pulses plus deformity or skin changes or previous ulcer) or 4) ulcerated foot within the preceding 15 months DM12 NM01 DM30 The percentage of patients with diabetes in whom the last blood pressure is 8 40-71% 150/90 or less in the preceding 15 months DM12 NM02 DM31 The percentage of patients with diabetes in whom the last blood pressure is 140/80 or less in the preceding 15 months 10 40-60% Page 2 of 6

MH9 NM15 MH11 The percentage of patients with schizophrenia, bipolar affective disorder and other psychoses who have a record of alcohol consumption in the preceding 15 months NM16 MH12 The percentage of patients with schizophrenia, bipolar affective disorder and other psychoses who have a record of BMI in the preceding 15 months NM17 MH13 The percentage of patients with schizophrenia, bipolar affective disorder and other psychoses who have a record of blood pressure in the preceding 15 months NM18 MH14 The percentage of patients aged 40 years and over with schizophrenia, bipolar affective disorder and other psychoses who have a record of total cholesterol:hdl ratio in the preceding 15 months NM19 MH15 The percentage of patients aged 40 years and over with schizophrenia, bipolar affective disorder and other psychoses who have a record of blood glucose level in the preceding 15 months NM20 MH16 The percentage of patients (aged from 25 to 64 in England and Northern Ireland, from 20 to 60 in Scotland and from 20 to 64 in Wales) with schizophrenia, bipolar affective disorder and other psychoses whose notes record that a cervical screening test has been performed in the preceding 5 years MH4 NM21 MH17 The percentage of patients on lithium therapy with a record of serum creatinine and TSH in the preceding 9 months MH5 NM22 MH18 The percentage of patients on lithium therapy with a record of lithium levels in the therapeutic range within the preceding 4 months DEP2 NM10 DEP4 In those patients with a new diagnosis of depression, recorded between the preceding 1 April to 31 March, the percentage of patients who have had an assessment of severity at the time of diagnosis using an assessment tool validated for use in primary care DEP3 NM11 DEP5 In those patients with a new diagnosis of depression and assessment of severity recorded between the preceding 1 April to 31 March, the percentage of patients who have had a further assessment of severity 4-12 weeks (inclusive) after the initial recording of the assessment of severity. Both assessments should be completed using an assessment tool validated for use in primary care 5 40-80% 5 40-80% 5 40-80% 1 40-90% 2 40-90% 17* 40-90% 8* 40-80% *Points reduced from 2010/11 to 2011/12 DEP4 reduced by 8 points and DEP5 reduced by 12 points Page 3 of 6

Replacement Indicators changed due to noteworthy coding or business logic amendments 2009/11 NICE 2011/12 QOF ID ID QOF ID 2011/12 Indicator Wording Points Threshold COPD1 - COPD1 The practice can produce a register of patients with COPD 3-4 COPD12 - COPD1 The percentage of all patients with COPD diagnosed after 1 April 2011 in whom 5 40-80% 5 the diagnosis had been confirmed by post bronchodilator spirometry MH6 - MH10 The percentage of patients on the register who have a comprehensive care plan documented in the records agreed between individuals, their family and/or careers as appropriate 6 25-50% New Indicators NICE 2011/12 ID QOF ID 2011/12 Indicator Wording Points Threshold NM03 EP9 The percentage of women under the age of 55 years who are taking antiepileptic 3 40-90% drugs who have a record of information and counselling about contraception, conception and pregnancy in the preceding 15 months NM04 LD2 Percentage of patients on the Learning Disability register with Down s Syndrome 3 40-70% aged 18 years and over who have a record of blood TSH in the preceding 15 months (excluding those who are on the thyroid disease register) NM09 DEM3 The percentage of patient with a new diagnosis of dementia from April 2011 to have 6 40-80% FBC, calcium, glucose, renal and liver function, thyroid function tests, serum vitamin B12 and folate levels recorded 6 months before or after entering on to the register - QP1 The practice conducts an internal review of their prescribing to assess whether it is 6 - clinically appropriate and cost effective, agrees with the PCO three areas for improvement and produces a draft plan for each area no later than 30 June 2011 - QP2 The practice participates in an external peer review of prescribing with a group of 7 - practices and agrees plans for three prescribing areas for improvement firstly with the group and then with the PCO no later than 30 September 2011 - QP3 The percentage of prescriptions complying with the agreed plan for the first improvement area as a percentage of all prescriptions in that improvement area during the period 1 January 2012 to 31 March 2012. 5 *Locally determined Page 4 of 6

*(Payment stages to be determined locally according to the method set out in the indicator guidance below with 20 percentage points between upper and lower thresholds) - QP4 The percentage of prescriptions complying with the agreed plan for the second improvement area as a percentage of all prescriptions in that improvement area during the period 1 January 2012 to 31 March 2012. *(Payment stages to be determined locally according to the method set out in the indicator guidance below with 20 percentage points between upper and lower thresholds) - QP5 The percentage of prescriptions complying with the agreed plan for the third improvement area as a percentage of all prescriptions in that improvement area during the period 1 January 2012 to 31 March 2012. *(Payment stages to be determined locally according to the method set out in the indicator guidance below with 20 percentage points between upper and lower thresholds) - QP6 The practice meets internally to review the data on secondary care outpatient referrals provided by the PCO - QP7 The practice participates in an external peer review with a group of practices to compare its secondary care outpatient referral data either with practices in the group of practices or with practices in the PCO area and proposes areas for commissioning or service design improvements to the PCO - QP8 The practice engages with the development of and follows three agreed care pathways for improving the management of patients in the primary care setting (unless in individual cases they justify clinical reasons for not doing this) to avoid inappropriate outpatient referrals and produces a report of the action taken to the PCO no later than 31 March 2012 - QP9 The practice meets internally to review the data on emergency admissions provided by the PCO QP10 The practice participates in an external peer review with a group of practices to compare its data on emergency admissions either with practices in the group of practices or practices in the PCO area and proposes areas for commissioning or Page 5 of 6 5 *Locally determined 5 *Locally determined 5-5 - 11-5 - 15 -

QP11 service design improvements to the PCO The practice engages with the development of and follows three agreed care pathways (unless in individual cases they justify clinical reasons for not doing this) in the management and treatment of patients in aiming to avoid emergency admissions and produces a report of the action taken to the PCO no later than 31 March 2012 27.5 - Reduced points change only in point value 2010/11 2011/12 QOF ID QOF ID Indicator Wording DEP1 DEP1 The percentage of patients on the diabetes register and/or the CHD register for whom case finding for depression has been undertaken on one occasion during the preceding 15 months using two standard screening questions BP4 BP4 The percentage of patients with hypertension in whom there is a record of the blood pressure in the preceding 9 months 2009/10 2010/12 Points Points Threshold 8 6 40-90% 18 16 40-90% Increased thresholds 2010/11 2011/12 QOF ID QOF ID Indicator Wording Points Threshold CHD6 CHD6 The percentage of patients with coronary heart disease in whom the last blood pressure reading (measured in the preceding 15 months) is 150/90 or less 17 40-71% STROKE6 STROKE6 The percentage of patients with a history of TIA or stroke in whom the last blood pressure reading (measured in the preceding 15 months) is 150/90 or less 5 40-71% DM12 DM30 The percentage of patients with diabetes in whom the last blood pressure is 150/90 or less 8 40-71% * Each of the above thresholds increased by one percentage point Page 6 of 6